Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Sep 22, 2017

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how HIV infection progresses in people who are receiving antiretroviral treatment (ART). Since HIV can now be managed as a long-term condition in many places, researchers want to learn more about the health challenges and complications that may arise over time, as well as any side effects from the treatments. By following a group of individuals on ART, the study aims to gather important information that can help improve care for people living with HIV.

To participate in this trial, individuals need to be at least 18 years old and have a confirmed HIV infection. They will also need to give their consent to take part in the study. The trial is currently recruiting participants of all genders. Those who join can expect regular follow-ups to monitor their health and the effects of their treatment. This research is crucial for developing better strategies for managing HIV and ensuring that patients receive the best possible care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged over 18 years old.
• • Confirmed HIV infection
• • Signed informed consent
• Exclusion Criteria:
• • HIV-2 infection